Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 158 | 0.690 |
Why?
|
| Premature Birth | 1 | 2022 | 112 | 0.690 |
Why?
|
| Autism Spectrum Disorder | 2 | 2017 | 179 | 0.470 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 57 | 0.460 |
Why?
|
| Glutamine | 1 | 2015 | 47 | 0.450 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 75 | 0.450 |
Why?
|
| Emotional Intelligence | 1 | 2013 | 4 | 0.420 |
Why?
|
| Oxytocin | 1 | 2013 | 45 | 0.400 |
Why?
|
| Schizophrenic Psychology | 1 | 2013 | 66 | 0.400 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 44 | 0.400 |
Why?
|
| Cognition | 2 | 2023 | 484 | 0.390 |
Why?
|
| Mental Disorders | 2 | 2023 | 791 | 0.360 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 158 | 0.360 |
Why?
|
| Schizophrenia | 1 | 2013 | 263 | 0.340 |
Why?
|
| Lens, Crystalline | 1 | 2007 | 16 | 0.280 |
Why?
|
| Cranial Irradiation | 1 | 2007 | 11 | 0.280 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 39 | 0.270 |
Why?
|
| Resilience, Psychological | 2 | 2018 | 60 | 0.270 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 36 | 0.250 |
Why?
|
| Biomimetics | 1 | 2006 | 30 | 0.250 |
Why?
|
| Oxygen | 1 | 2006 | 317 | 0.220 |
Why?
|
| Stem Cells | 1 | 2006 | 259 | 0.220 |
Why?
|
| Glucose | 1 | 2006 | 467 | 0.200 |
Why?
|
| Fragile X Syndrome | 1 | 2022 | 26 | 0.190 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1358 | 0.180 |
Why?
|
| Petroleum Pollution | 2 | 2018 | 3 | 0.180 |
Why?
|
| Models, Biological | 1 | 2006 | 1180 | 0.170 |
Why?
|
| Emotions | 1 | 2023 | 223 | 0.170 |
Why?
|
| Cyclonic Storms | 2 | 2018 | 22 | 0.170 |
Why?
|
| Social Capital | 1 | 2018 | 5 | 0.150 |
Why?
|
| Loneliness | 1 | 2018 | 19 | 0.150 |
Why?
|
| Disasters | 1 | 2018 | 29 | 0.140 |
Why?
|
| Humans | 14 | 2023 | 63443 | 0.140 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 39 | 0.140 |
Why?
|
| Survivors | 1 | 2018 | 171 | 0.130 |
Why?
|
| Child | 4 | 2023 | 4526 | 0.130 |
Why?
|
| Adolescent | 4 | 2023 | 6245 | 0.130 |
Why?
|
| Intelligence | 1 | 2015 | 52 | 0.110 |
Why?
|
| Creatinine | 1 | 2015 | 134 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 268 | 0.110 |
Why?
|
| Depression | 2 | 2018 | 894 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 294 | 0.110 |
Why?
|
| Psychopathology | 1 | 2013 | 21 | 0.100 |
Why?
|
| Oxytocics | 1 | 2013 | 14 | 0.100 |
Why?
|
| Communication Disorders | 1 | 2013 | 17 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 119 | 0.100 |
Why?
|
| Epigenomics | 1 | 2013 | 62 | 0.100 |
Why?
|
| Age of Onset | 1 | 2013 | 174 | 0.100 |
Why?
|
| Social Behavior | 1 | 2013 | 89 | 0.100 |
Why?
|
| Child Behavior | 1 | 2013 | 64 | 0.100 |
Why?
|
| Psychotropic Drugs | 1 | 2013 | 84 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 151 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1408 | 0.090 |
Why?
|
| Female | 6 | 2023 | 32878 | 0.090 |
Why?
|
| Male | 7 | 2023 | 29889 | 0.090 |
Why?
|
| Psychiatry | 1 | 2013 | 125 | 0.090 |
Why?
|
| Mobile Applications | 1 | 2013 | 136 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2013 | 144 | 0.090 |
Why?
|
| Social Media | 1 | 2013 | 128 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 978 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 1120 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 772 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 724 | 0.070 |
Why?
|
| Mississippi | 2 | 2018 | 16 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2017 | 1990 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2007 | 10 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2007 | 12 | 0.070 |
Why?
|
| Proton Therapy | 1 | 2007 | 8 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2007 | 66 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2007 | 132 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 49 | 0.060 |
Why?
|
| Pregnancy Proteins | 1 | 2006 | 16 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 78 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 19 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 14 | 0.060 |
Why?
|
| Lymphokines | 1 | 2005 | 67 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 763 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 213 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 103 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2006 | 477 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 160 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1558 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2022 | 34 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2022 | 38 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 988 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2157 | 0.050 |
Why?
|
| Adult | 3 | 2018 | 16823 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1008 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5462 | 0.030 |
Why?
|
| Office Visits | 1 | 2017 | 48 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 2570 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1537 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1147 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 36 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2334 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 266 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 317 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 376 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 568 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 694 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 20663 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 470 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 232 | 0.020 |
Why?
|
| Informed Consent | 1 | 2013 | 140 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 14446 | 0.020 |
Why?
|
| Data Collection | 1 | 2013 | 383 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2006 | 1469 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 17612 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 419 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2680 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 597 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4694 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2006 | 16 | 0.020 |
Why?
|
| Placenta Growth Factor | 1 | 2006 | 15 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2006 | 51 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 145 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 200 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 140 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 167 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 61 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 229 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 519 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 453 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 896 | 0.010 |
Why?
|
| Mice | 2 | 2006 | 10844 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 618 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 1172 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7842 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 921 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2187 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 3035 | 0.010 |
Why?
|